From Europe PMC via Jisc Publications RouterHistory: ppub 2021-07-01, epub 2021-07-29Publication status: PublishedFunder: Medical Research Council; Grant(s): (MR/M01665X/1)BackgroundSystemic lupus erythematosus (SLE) is a heterogeneous systemic autoimmune condition for which there are limited licensed therapies. Clinical trial design is challenging in SLE due at least in part to imperfect outcome measures. Improved understanding of how disease activity changes over time could inform future trial design. The aim of this study was to determine whether distinct trajectories of disease activity over time occur in patients with active SLE within a clinical trial setting and to identify factors associated with these trajectories.MethodsLatent cla...
To access publisher's full text version of this article. Please click on the hyperlink in Additional...
Background: The aim was to assess the attainability and outcome of the lupus low disease activity st...
Objectives: We evaluated a monocentric SLE cohort in order to assess the frequency of Lupus comprehe...
From Springer Nature via Jisc Publications RouterHistory: received 2021-02-15, accepted 2021-07-10, ...
From PubMed via Jisc Publications RouterHistory: received 2021-02-15, accepted 2021-07-10Publication...
ObjectiveTo obtain real-world data on outcomes of belimumab treatment and respective prognostic fact...
ObjectiveTo obtain real-world data on outcomes of belimumab treatment and respective prognostic fact...
OBJECTIVES: To describe the baseline characteristics of SLE patients requiring biologic therapy in t...
Major scientific advances in basic science, pharmacology, and translational medicine have allowed th...
ObjectiveMost clinical trials for systemic lupus erythematosus (SLE) study the efficacy and safety o...
ObjectiveTo obtain real-world data on outcomes of belimumab treatment and respective prognostic fact...
OBJECTIVES: The aim was to characterize disease severity, clinical manifestations, treatment pattern...
macology, and translational medicine have allowed the dis-covery of new molecular targets whose mani...
The goal of this work was to develop an economical way of tracking disease activity for large groups...
Systemic Lupus Erythematosus (SLE) is a chronic, autoimmune disease with heterogeneous symptoms, ma...
To access publisher's full text version of this article. Please click on the hyperlink in Additional...
Background: The aim was to assess the attainability and outcome of the lupus low disease activity st...
Objectives: We evaluated a monocentric SLE cohort in order to assess the frequency of Lupus comprehe...
From Springer Nature via Jisc Publications RouterHistory: received 2021-02-15, accepted 2021-07-10, ...
From PubMed via Jisc Publications RouterHistory: received 2021-02-15, accepted 2021-07-10Publication...
ObjectiveTo obtain real-world data on outcomes of belimumab treatment and respective prognostic fact...
ObjectiveTo obtain real-world data on outcomes of belimumab treatment and respective prognostic fact...
OBJECTIVES: To describe the baseline characteristics of SLE patients requiring biologic therapy in t...
Major scientific advances in basic science, pharmacology, and translational medicine have allowed th...
ObjectiveMost clinical trials for systemic lupus erythematosus (SLE) study the efficacy and safety o...
ObjectiveTo obtain real-world data on outcomes of belimumab treatment and respective prognostic fact...
OBJECTIVES: The aim was to characterize disease severity, clinical manifestations, treatment pattern...
macology, and translational medicine have allowed the dis-covery of new molecular targets whose mani...
The goal of this work was to develop an economical way of tracking disease activity for large groups...
Systemic Lupus Erythematosus (SLE) is a chronic, autoimmune disease with heterogeneous symptoms, ma...
To access publisher's full text version of this article. Please click on the hyperlink in Additional...
Background: The aim was to assess the attainability and outcome of the lupus low disease activity st...
Objectives: We evaluated a monocentric SLE cohort in order to assess the frequency of Lupus comprehe...